10 Stocks Moving In Tuesday's Pre-Market Session

Gainers

Exelixis, Inc. EXEL shares rose 13.74 percent to $4.14 in pre-market trading on its Q4 earnings call and the announcement of an exclusive licensing agreement, with Ipsen IPSEY, for the commercialization and further development of cabozantinib, Exelixis’ main oncology drug. The company retrieved a fourth quarter net loss of $0.19 per share on revenue of $9.9 million.

21Vianet Group Inc VNET rose 6.72 percent to $18.74 in pre-market trading. 21Vianet Group is expected to release its Q4 financial results on March 10, 2016.

Halozyme Therapeutics, Inc. HALO shares rose 6.40 percent to $8.65 in pre-market trading after the company reported upbeat Q4 results.

Celldex Therapeutics, Inc. CLDX shares rose 6.32 percent to $7.23 in pre-market trading. H.C. Wainwright initiated coverage on Celldex Therapeutics with a Buy rating and a $25.00 price target.

JD.Com Inc(ADR) JD shares rose 3.19 percent to $26.53 in the pre-market trading session after the company reported upbeat Q4 results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

Rockwell Medical Inc RMTI shares fell 36.35 percent to $6.11 in pre-market trading after the company reported downbeat results for its fourth quarter on Monday.

Diplomat Pharmacy Inc DPLO shares fell 25.74 percent to $26.45 in pre-market trading following the announcement of the company’s Q4 financial results. The company posted earnings of $0.21 per share on revenue of $987 million.

Sunedison Inc SUNE shares fell 20.20 percent to $1.58 in pre-market trading as the company reported that it is delaying its annual report. Oppenheimer downgraded SunEdison from Outperform to Perform.

Marathon Oil Corporation MRO shares fell 5.48 percent to $7.77 in pre-market trading after the company announced a public offering of 145 million shares of its stock.

Dollar Tree, Inc. DLTR shares fell 4.67 percent to $76.50 in pre-market trading as the company reported weaker-than-expected results for its fourth quarter.